DRUG Bright Minds Biosciences
- 48.1800
- +1.3800+2.95%
- 48.2100
- +0.0300+0.06%
Bright Minds Biosciences News
Express News | Point72 Asset Management, L.p. Reports 9.7% Passive Stake in Bright Minds Biosciences as of Oct 16 - SEC Filing
Soaring $1-handle Stocks Leaping Into IBKR's Most-active List May Point to Market Froth
Cormorant Asset Management's Strategic Acquisition of Bright Minds Biosciences Shares
What's Going On With Bright Minds Biosciences Stock?
Bright Minds, Firefly Team Up to Analyze Data of Phase 2 Study of BMB-101 to Treat Epilepsy; Shares Rise
Express News | Bright Minds Biosciences Shares Halted On Circuit Breaker To The Upside, Stock Now Up 27%
Bright Minds and Firefly Neuroscience Collaborate for EEG Data in Receptor Agonist Study
Express News | Bright Minds Biosciences Announces Collaboration With Firefly Neuroscience To Provide A Full Analysis Of EEF Data In The BREAKTHROUGH Trial
Trending Stocks Today | GRI Bio Shoots up 191.37% Pre-Market
Biggest Stock Movers Monday: BA, SAVE, and More
FDA Is Said to See "Path Forward" for Ecstasy-based Drug
Trending Stocks Today | VSee Health Soars 44.51% Post-Market
Top Midday Gainers
Trending Stocks Today | 1847 Holdings Surges 200.46%
What's Going On With Bright Minds Biosciences Stock Friday?
U.S. stock market anomaly | Planning to conduct a $0.175 billion non-broker private placement, Bright Minds Biosciences (DRUG.US) soared 52 times in 5 trading days.
On Friday, Bright Minds Biosciences (DRUG.US) opened again with a significant increase, skyrocketing 52 times in 5 trading days, hitting a historical high. As of the time of writing, it rose more than 165%, trading at $57.72.
Bright Minds Biosciences Shares Surge 70% on $35M Private Placement
Bright Minds Biosciences Shares Halted To The Upside; Stock Now Up 81.66%
Sector Update: Health Care Stocks Steady Pre-Bell Friday
Express News | Market-Moving News for October 18th
Analysis
Price Target
No Data
No Data